Tag: asymptomatic

New data from Addenbrooke’s Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by four-fold the number of asymptomatic SARS-CoV-2 infections. This implies that the vaccine could significantly reduce the risk of transmission of the virus from people who are asymptomatic, as well as protecting others from getting ill.

New research suggests when the COVID-19 pandemic is slowing, low-cost, recurring screening of asymptomatic people—at an expense of approximately $3 or less per test every two weeks—could decrease COVID-19 infections and deaths and be cost-effective. When the pandemic is surging, screening can be cost-effective when done more often, even if tests costs are higher. The

Coronavirus updated cases around the world sits at 3.5 million infections and 284,000 deaths. In a glimmer of hope during this pandemic, 1.13 million people have recovered from COVID-19. Thanks in part, to efficient medical care, no underlying health conditions and spotting their symptoms early. What makes COVID-19 such a destructive virus is that there